Doxazosin in benign prostatic hyperplasia: Effects on blood pressure and urinary flow in normotensive and hypertensive men
- 1 August 1995
- Vol. 46 (2) , 182-186
- https://doi.org/10.1016/s0090-4295(99)80191-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A three month double‐blind study of doxazosin as treatment for benign prostatic bladder outlet obstructionBritish Journal of Urology, 1994
- 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meetingJournal Of Hypertension, 1993
- Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society.BMJ, 1993
- The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)Archives of internal medicine (1960), 1993
- Doxazosin Treatment in Patients with Prostatic ObstructionScandinavian Journal of Urology and Nephrology, 1993
- Efficacy and Safety of the Alpha-1 Blocker Doxazosin in the Treatment of Benign Prostatic HyperplasiaEuropean Urology, 1993
- High prevalence of benign prostatic hypertrophy in the communityThe Lancet, 1991
- Characterisation of Human Prostatic Adrenoceptors using Pharmacology Receptor Binding and LocalisationBritish Journal of Urology, 1989
- Characterization of Alpha 1 Adrenergic Receptors in Human Benign Prostatic HyperplasiaJournal of Urology, 1984
- Alpha-Adrenergic Activity and Urethral Pressure in Prostatic Zone in Benign Prostatic HypertrophyJournal of Urology, 1982